These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29831)

  • 1. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Findings of biochemical research on schizophrenia (author's transl)].
    Ackenheil M; Hippius H; Matussek N
    Nervenarzt; 1978 Nov; 49(11):634-49. PubMed ID: 31575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biogenic amines and schizophrenia].
    Schöpf J
    Schweiz Med Wochenschr; 1975 Sep; 105(38):1201-9. PubMed ID: 1061994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet enzyme abnormalities in neuropsychiatric disease.
    Farmer PM
    Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dopanergic agonists and schizophrenia].
    Pidgeon JF; Wolf MA
    Psychiatr J Univ Ott; 1989 Nov; 14(4):529-35. PubMed ID: 2573101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.
    Murphy DL; Wyatt RJ
    Nature; 1972 Jul; 238(5361):225-6. PubMed ID: 4558353
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.